Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31159 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Lise Marie Krogh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Bone Remodeling, Hematopoietic Stem Cell Transplantation, Resistance Training. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Danish Childhood Cancer Foundation, Independent Research Foundation Denmark, Research Foundation of Rigshospitalet - Copenhagen University Hospital.
Abstract (Originalsprache)
Background
Early‐onset osteoporosis is a frequent late effect after pediatric hematopoietic stem cell transplantation (HSCT). It remains unknown if physical training can improve bone formation in these patients, as the transplantation procedure may cause sustained dysregulation of the bone‐forming osteoblast progenitor cells.
Objective
We aimed to explore the effect of resistance training on bone remodeling in long‐term survivors of pediatric HSCT. Procedure In this prospective, controlled intervention study, we included seven HSCT survivors and 15 age‐ and sex‐matched healthy controls. The participants completed a 12‐week heavy load, lower extremity resistance training intervention with three weekly sessions. We measured fasting serum levels of the bone formation marker “N‐terminal propeptide of type I procollagen” (P1NP), and the bone resorption marker “C‐terminal telopeptide of type I collagen” (CTX). The hypothesis was planned before data collection began. The trial was registered at Clinicaltrials.gov before including the first participant, with trial registration no. NCT04922970.
Results
Resistance training led to significantly increased levels of fasting P1NP in both patients (from 57.62 to 114.99 ng/mL, p = .03) and controls (from 66.02 to 104.62 ng/mL, p < .001). No significant changes in fasting CTX levels were observed.
Conclusions
Despite previous high‐dose cytotoxic therapy, long‐term survivors of pediatric HSCT respond to resistance training with improvement of bone formation, comparable to that of healthy controls. This suggests that resistance training might be a promising non‐pharmacological approach to prevent the early decline in bone mass, and should be considered as part of a follow‐up program to counteract long‐term sequela after pediatric HSCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Institute for Inflammation Research, Center for Rheumatology and Spine Disease, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Institute of Sports Medicine Copenhagen, Department of Orthopaedic Surgery, Copenhagen University Hospital - Bispebjerg & Frederiksberg, Copenhagen, Denmark.
- Center for Healthy Aging, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Bone Marrow Transplantation and Immunodeficiency, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Anne Nissen, Sarah Weischendorff, Martin Kaj Fridh
Förderung
- Danish Childhood Cancer Foundation
- Independent Research Foundation Denmark
- Research Foundation of Rigshospitalet - Copenhagen University Hospital
- Danish Cancer Research Foundation
- Master Carpenter Jørgen Holm and wife Elisa F. Hansen's Memorial Trust
- Svend Andersen Foundation,
- Lundbeck Foundation
- Børnecancerfonden
Zitieren
APA
Krogh, L. M., Nissen, A., Weischendorff, S., Hartmann, B., Andersen, J. L., Holst, J. J., Sørensen, K., Fridh, M. K., Mackey, A. L., & Müller, K. (2024). Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31159
Vancouver
Krogh LM, Nissen A, Weischendorff S, Hartmann B, Andersen JL, Holst JJ, et al. Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31159
BibTeX
@article{Krogh2024,
author = {Krogh, Lise Marie and Nissen, Anne and Weischendorff, Sarah and Hartmann, Bolette and Andersen, Jesper Løvind and Holst, Jens Juul and Sørensen, Kaspar and Fridh, Martin Kaj and Mackey, Abigail Louise and Müller, Klaus},
title = {Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31159}
}
EUVIMED